Período de transición del niño y el adolescente a la adultez tratado con Hormona de Crecimiento Recombinante (RHGH). Una realidad
Date
Subject
Transition period
Growth Hormone Deficiency
hypopituitarism
short stature
período de transición
hipopituitarismo
deficiencia de hormona de crecimiento
Growth Hormone Deficiency
hypopituitarism
short stature
período de transición
hipopituitarismo
deficiencia de hormona de crecimiento
Language:
Journal Title
Journal ISSN
Volume Title
Publisher
Intituto Tecnológico de Santo Domingo (INTEC)
La baja talla por Deficiencia de Hormona de Crecimiento es una de las causas endocrinas más frecuentes. El tratamiento se realiza con hormona de crecimiento recombinante (rhgh) durante un período habitualmente de larga duración. Existe un grupo de pacientes que su tratamiento con hormona de crecimiento no concluye en la adultez y debe ser tratado también en ese periodo de la vida. El tema de las transferencias se planteó por primera vez en Estados Unidos en 1984, como consecuencia del importante aumento de supervivencia durante los años setenta y ochenta de niños con patología crónica y discapacitante. Se entiende por transición a una etapa de cambios físicos y psicológicos que, de forma arbitraria, se extiende desde el final de la pubertad hasta que la maduración adulta se completa. Es preciso reevaluar los pacientes con deficiencia de hormona de crecimiento tras alcanzar la talla adulta y definir el estado de la secreción de GH para valorar la conti el periodo de transición y en la adultez.
The sort stature due to growth hormone deficiency is one of the most frequent endocrine cause. The treatment is carried out with recombinant growth hormone (rhgh) for a period of usually long duration. There is a group of patients treatment with growth hormone does not end in adulthood and should also be treated at that period of life. The issue of transfers we first raises in United States in 1984, as a consequence of the significant increase in survival during 1970-1080 in children with chronic and disabling diseases. The transition period from child to adult represents a crucial phase in the growth process where multiple physical and psychosocial changes occur. It has been arbitrarily defined as the period extending from late puberty to full adult maturity. It is necessary to reassessment patient with Growth Hormone Deficiency after that to arrive the adult height and to define the GH secretion status for to evaluate the continuity of replace treatment during the transition and adult period.
The sort stature due to growth hormone deficiency is one of the most frequent endocrine cause. The treatment is carried out with recombinant growth hormone (rhgh) for a period of usually long duration. There is a group of patients treatment with growth hormone does not end in adulthood and should also be treated at that period of life. The issue of transfers we first raises in United States in 1984, as a consequence of the significant increase in survival during 1970-1080 in children with chronic and disabling diseases. The transition period from child to adult represents a crucial phase in the growth process where multiple physical and psychosocial changes occur. It has been arbitrarily defined as the period extending from late puberty to full adult maturity. It is necessary to reassessment patient with Growth Hormone Deficiency after that to arrive the adult height and to define the GH secretion status for to evaluate the continuity of replace treatment during the transition and adult period.
Description
Type
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/publishedVersion
Source
Science and Health; Vol 4 No 2 (2020): Science and Health, may-August; 13-20
Ciencia y Salud; Vol. 4 Núm. 2 (2020): Ciencia y Salud, mayo-agosto; 13-20
2613-8824
2613-8816
10.22206/cysa.2020.v4i2
Ciencia y Salud; Vol. 4 Núm. 2 (2020): Ciencia y Salud, mayo-agosto; 13-20
2613-8824
2613-8816
10.22206/cysa.2020.v4i2